The Vigabatrin REMS Program is needed by the FDA to make certain educated risk-benefit decisions before launching treatment, and to ensure proper use vigabatrin while clients are treated. It is not possible for your doctor to recognize when vision loss will take place.
One of the most common side effect of SABRIL in children 3 to 16 years is weight gain. With serious vision loss, you may just be able to see things right in front of you (often called one-track mind"). You go to threat for vision loss with any amount of SABRIL.
If you are pregnant or intend to get expectant, tell your healthcare company. If vision testing can not be done, your doctor may continue recommending SABRIL, but will certainly not have the ability to look for any vision loss. If vision tests are refrained from doing regularly, your healthcare provider might stop suggesting SABRIL for you (or your kid).